24(top 1%)
papers
1.1K(top 1%)
citations
13(top 1%)
h-index
21(top 1%)
g-index
25
all documents
1.2K
doc citations
489
citing journals

Top Articles

#TitleJournalYearCitations
1Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastasesAnnals of Oncology2018388
2Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung CancerJournal of Clinical Oncology2021329
3Pain in Parkinson disease: A review of the literatureParkinsonism and Related Disorders2013122
4Pregnancy after uterine fibroid embolization: follow-up of 100 patients embolized using tris-acryl gelatin microspheresFertility and Sterility200855
5Evaluation of intervertebral disc herniation and hypermobile intersegmental instability in symptomatic adult patients undergoing recumbent and upright MRI of the cervical or lumbosacral spinesEuropean Journal of Radiology200750
6P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)Journal of Thoracic Oncology201638
7Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets).Journal of Clinical Oncology201631
8OA14.04 Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLCJournal of Thoracic Oncology201929
9Targeting FGFR1-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398.Journal of Clinical Oncology201427
10A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC).Journal of Clinical Oncology201527
11Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in SpainActa Paediatrica, International Journal of Paediatrics201024
12Deep Tissue Hypersensitivity to Pressure Pain in Individuals with Unilateral Acute Inversion Ankle SprainPain Medicine201217
13Abstract CT195: Long-term survival outcomes with nivolumab (NIVO) in pts with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and responseCancer Research201913
14Low-dose spinal anesthesia for urgent laparotomy in severe myasthenia gravisSaudi Journal of Anaesthesia20138
15Eficacia y seguridad de un tratamiento oral a base de mucopolisacáridos, colágeno tipo i y vitamina C en pacientes con tendinopatíasApunts Medicine De L'Esport20146
16From Node to Pathway Blockade: Lessons Learned From Targeting Mammalian Target of RapamycinJournal of Clinical Oncology20125
17Lurbinectedin (PM01183) with doxorubicin (DOX), an active treatment as second-line therapy in small cell lung cancer (SCLC).Journal of Clinical Oncology20153
18Influencing cancer treatmentLancet Oncology, The20152
19Tumor infiltrating lymphocytes before and after dual HER2 blockade in HER2-amplified early breast cancer: A TRYPHAENA substudy.Journal of Clinical Oncology20162
20A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM), pemetrexed (PEM) & carboplatin (CARBO) in pts with 1st line non-squamous NSCLC.Journal of Clinical Oncology20151
21P3.07-012 Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver MetastasesJournal of Thoracic Oncology20170
22Implantes con grabado ácido y pasivado químico: estudio preliminar sobre carga precozAvances En Periodoncia E ImplantologÍa Oral20010
23High level of suppressor-of-fused (SuFu) expression and tumor cells dissemination in human glioblastoma.Journal of Clinical Oncology20140
24GBM cell microvesicles carrying gDNA oncogenic sequences cross the BBB and reach the peripheral blood.Journal of Clinical Oncology20140